You have 9 free searches left this month | for more free features.

adult anaplastic astrocytoma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma Trial in Rochester (procedure,

Active, not recruiting
  • Adult Anaplastic Astrocytoma
  • +15 more
  • biopsy
  • +7 more
  • Rochester, Minnesota
    Mayo Clinic
Apr 8, 2022

Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children,

Not yet recruiting
  • Anaplastic Astrocytoma
  • +17 more
    • (no location specified)
    Jun 28, 2023

    Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma Trial in Duarte (biological,

    Completed
    • Adult Anaplastic Astrocytoma
    • +6 more
    • E. coli CD-expressing genetically modified neural stem cells
    • +4 more
    • Duarte, California
      City of Hope Medical Center
    Sep 28, 2021

    Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Diffuse Astrocytoma Trial in New York (other, drug,

    Completed
    • Adult Anaplastic Astrocytoma
    • +8 more
    • Laboratory Biomarker Analysis
    • +3 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jun 28, 2021

    Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Miami (biological, drug, procedure)

    Completed
    • Malignant Glioma
    • +3 more
    • Dendritic Cell Vaccine
    • +3 more
    • Miami, Florida
      University of Miami
    Jul 19, 2022

    CNS Tumors, Glioblastoma, Gliosarcoma, Adult Trial run by the (ONC206)

    Recruiting
    • Central Nervous System Neoplasms
    • +22 more
    • Bethesda, Maryland
      National Institutes of Health
    Mar 1, 2022

    Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Oligodendroglioma Trial in United States (other, drug, procedure)

    Active, not recruiting
    • Anaplastic Astrocytoma
    • +6 more
    • Laboratory Biomarker Analysis
    • +4 more
    • Los Angeles, California
    • +11 more
    Jul 1, 2022

    Glioblastoma Multiforme, Anaplastic Astrocytoma, Gliosarcoma Trial in Birmingham (M032, Pembrolizumab)

    Recruiting
    • Glioblastoma Multiforme
    • +2 more
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Jan 30, 2023

    Astrocytoma, Glioblastoma Trial in Spain, United States (CC-90010)

    Active, not recruiting
    • Astrocytoma
    • Glioblastoma
    • Jacksonville, Florida
    • +8 more
    Dec 14, 2022

    IDH Family Wildtype, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma Trial in Houston (Laser Interstitial Thermal

    Terminated
    • IDH Family Wildtype
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 14, 2022

    Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Bevacizumab)

    Recruiting
    • Glioblastoma Multiforme
    • Anaplastic Astrocytoma
    • New York, New York
      Lenox Hill Brain Tumor Center
    Nov 10, 2022

    Glioblastoma, Anaplastic Astrocytoma, Astrocytoma Trial in New York (Adaptive Radiotherapy)

    Recruiting
    • Glioblastoma
    • +3 more
    • Adaptive Radiotherapy
    • New York, New York
      Columbia University Irving Medical Center
    Oct 27, 2023

    Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Duarte, Chicago (Neural stem cells loaded with an

    Completed
    • Glioma
    • +7 more
    • Neural stem cells loaded with an oncolytic adenovirus
    • Duarte, California
    • +1 more
    Dec 28, 2022

    Astrocytoma, IDH-Mutant, Grade 2, Astrocytoma, IDH-Mutant, Grade 3 Trial in United States (other, radiation, drug)

    Active, not recruiting
    • Astrocytoma, IDH-Mutant, Grade 2
    • Astrocytoma, IDH-Mutant, Grade 3
    • Questionnaire Administration
    • +3 more
    • Phoenix, Arizona
    • +24 more
    Dec 7, 2022

    Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma Trial in United States (drug,

    Terminated
    • Adult Anaplastic Astrocytoma
    • +4 more
    • Chicago, Illinois
    • +4 more
    Feb 27, 2020

    Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial (PCI 24781, Temozolomide)

    Not yet recruiting
    • Recurrent High Grade Glioma
    • +4 more
    • (no location specified)
    Jan 24, 2023

    Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma Trial in New York (Intra-arterial Cetuximab, Intra-arterial

    Recruiting
    • Glioblastoma
    • +8 more
    • Intra-arterial Cetuximab
    • +2 more
    • New York, New York
      Lenox Hill Brain Tumor Center
    Oct 17, 2022

    Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in United States (INCB7839)

    Recruiting
    • Glioblastoma Multiforme
    • +5 more
    • Los Angeles, California
    • +12 more
    Jan 9, 2023

    Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Bevacizumab and Carboplatin)

    Suspended
    • Glioblastoma Multiforme
    • Anaplastic Astrocytoma
    • Bevacizumab and Carboplatin
    • New York, New York
      Lenox Hill Brain Tumor Center
    Oct 27, 2021

    Glioblastoma Multiforme of Brain, Anaplastic Astrocytoma of Brain, Gliosarcoma of Brain Trial in Birmingham (C134)

    Active, not recruiting
    • Glioblastoma Multiforme of Brain
    • +2 more
    • C134
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Sep 19, 2022

    Medulloblastoma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Buffalo, New York, Cincinnati (SurVaxM for patients

    Recruiting
    • Medulloblastoma
    • +7 more
    • SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years
    • +2 more
    • Buffalo, New York
    • +2 more
    Jul 8, 2022

    Loupe-Based Intraoperative Fluorescence Imaging

    Recruiting
    • Glioblastoma Multiforme
    • Anaplastic Astrocytoma
      • Lexington, Kentucky
        University of Kentucky
      Mar 3, 2022

      Brain Tumor, Astrocytoma, Astroglioma Trial run by the NCI (Zotiraciclib (TG02), Temozolomide (TMZ))

      Completed
      • Brain Tumor
      • +4 more
      • Zotiraciclib (TG02)
      • Temozolomide (TMZ)
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Sep 3, 2021

      Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,

      Recruiting
      • Anaplastic Astrocytoma, IDH-Wildtype
      • +8 more
      • Quality-of-Life Assessment
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 8, 2022